Nonallergic rhinitis symptoms more severe than allergic rhinitis
Key points
- A comparison of symptoms in patients with allergic rhinitis (AR) and non-allergic rhinitis (NAR) revealed that those with the NAR experienced worse symptoms.
- The Academy serves its members by facilitating the advancement of the science and art of medicine related to otolaryngology and by representing the specialty in governmental and socioeconomic issues.
- The study assessed 78 patients with AR and 31 patients with non-allergic rhinitis (NAR), measuring quality of life (QOL) in both groups using a common questionnaire.
- The study's authors believe that that many patients with allergy-type symptoms may have other, as-yet-undetermined causes of their symptoms, and that further research is warranted.
A comparison of symptoms in patients with allergic rhinitis (AR) and non-allergic rhinitis (NAR) revealed that those with the NAR experienced worse symptoms. The findings are according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA.
The study assessed 78 patients with AR and 31 patients with non-allergic rhinitis (NAR), measuring quality of life (QOL) in both groups using a common questionnaire. To the surprise of the authors, NAR patients experienced a significantly higher symptom severity than their peers with AR, including having their regular and recreational activities affected, disrupted sleep, tiredness, and watery eyes.
The study's authors believe that that many patients with allergy-type symptoms may have other, as-yet-undetermined causes of their symptoms, and that further research is warranted.
###
Title: Quality of Life in Allergic and Non-Allergic Rhinitis
Author: Nick Debnath, MD; Rodney J. Schlosser, MD; Richard J. Harvey; Shaun A. Nguyen, MD, MA; Charley S. Coffey, MD; Karen M. Drawdy, PA-C
Date: Monday, October 5, 2009, 9:30-10:20 am
Information for the Media: The AAO-HNSF Annual Meeting & OTO EXPO Newsroom will be located in the San Diego Convention Center, Mezzanine Level, Room 14A. Hours of operation: Saturday, October 3, 12 pm to 5 pm; Sunday-Tuesday, October 4- 6, 7:30 am to 5 pm; and Wednesday, October 7, 7:30 am to 2 pm (all hours Pacific time). The newsroom serves as a work space for credentialed members of the news media. The newsroom is managed and staffed by the AAO-HNS Communications Unit. Please see the AAO-HNS website for media credentialing requirements for the event.
Onsite Newsroom contact: 1-619-525-6202
About the AAO-HNS
The American Academy of Otolaryngology – Head and Neck Surgery (http://www.entnet.org), one of the oldest medical associations in the nation, represents more than 12,000 physicians and allied health professionals who specialize in the diagnosis and treatment of disorders of the ears, nose, throat, and related structures of the head and neck. The Academy serves its members by facilitating the advancement of the science and art of medicine related to otolaryngology and by representing the specialty in governmental and socioeconomic issues. The organization's vision: "Empowering otolaryngologist-head and neck surgeons to deliver the best patient care."
Contact: Matt Daigle
newsroom@entnet.org
703-535-3754
American Academy of Otolaryngology - Head and Neck Surgery
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Lungs, Asthma & Allergies →NewsChildren with milk allergy may be 'allergic to school'
Many of today's school teachers opt for dustless chalk to keep hands and classrooms clean. But according to a study published in the May issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the…
2 May 2013
NewsAsthma drug found highly effective in treating chronic, severe hives and itch
An international team of researchers has found that a once-a-month, high-dose injection of a commonly used asthma drug is highly effective in treating teens and adults chronically afflicted with hives and severe, itchy…
25 February 2013
NewsBronchiectasis increases mortality risk in moderate-to-severe COPD
Bronchiectasis is independently associated with an increased mortality risk in patients with moderate-to-severe COPD, according to a new study from researchers in Spain. Bronchiectasis, a permanent and progressive…
